武汉云克隆科技股份有限公司

G补缀FHA域血管生成因子1(AGGF1)多克隆抗体

Polyclonal Antibody to Angiogenic Factor With G Patch And FHA Domains 1 (AGGF1)

GPATC7; GPATCH7; VG5Q; Angiogenic factor VG5Q; G patch domain-containing protein 7; Vasculogenesis gene on 5q protein

  • G补缀FHA域血管生成因子1(AGGF1)多克隆抗体产品包装(模拟)
  • G补缀FHA域血管生成因子1(AGGF1)多克隆抗体产品包装(模拟)
  • G补缀FHA域血管生成因子1(AGGF1)多克隆抗体Used in DAB staining on fromalin fixed paraffin-embedded Intestine tissue
  • PAL178Hu02.jpgWB图
  • G补缀FHA域血管生成因子1(AGGF1)多克隆抗体Western Blot; Samples: Lane1: 293T cell lysate; Lane2: Hela cell lysate;
    Primary Ab: 0.1µg/ml Rabbit Anti-Human AGGF1 Antibody
    Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • Certificate通过ISO 9001、ISO 13485质量体系认证

特异性

该抗体是针对AGGF1的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别AGGF1。

用法

免疫印迹：0.2-2µg/mL;1:250-2500
免疫组织化学：5-20µg/mL;1:25-100
免疫细胞化学：5-20µg/mL;1:25-100
最佳稀释倍数最终由用户决定。

储存

经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。

赠品

相关产品

编号适用物种：Homo sapiens (Human，人)应用(仅供研究使用，不用于临床诊断！)
RPL178Hu01G补缀FHA域血管生成因子1(AGGF1)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPL178Hu02G补缀FHA域血管生成因子1(AGGF1)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAL178Hu01G补缀FHA域血管生成因子1(AGGF1)多克隆抗体WB; IHC; ICC; IP.
PAL178Hu02G补缀FHA域血管生成因子1(AGGF1)多克隆抗体WB; IHC; ICC; IP.
LAL178Hu71G补缀FHA域血管生成因子1(AGGF1)多克隆抗体(生物素标记)WB; IHC; ICC.
MAL178Hu21G补缀FHA域血管生成因子1(AGGF1)单克隆抗体WB; IHC; ICC; IP.
SEL178HuG补缀FHA域血管生成因子1(AGGF1)检测试剂盒(酶联免疫吸附试验法)Enzyme-linked immunosorbent assay for Antigen Detection.
LML178HuG补缀FHA域血管生成因子1(AGGF1)等多因子检测试剂盒(流式荧光发光法)FLIA Kit for Antigen Detection.

参考文献

杂志参考文献
Biochimica et Biophysica Acta (BBA) - Molecular Basis of DiseaseRole of microRNA-27a in down-regulation of angiogenic factor AGGF1 under hypoxia associated with high-grade bladder urothelial carcinoma[Pubmed:24462738]
Cancer Management and ResearchIL-17 induces macrophages to M2-like phenotype via NF-κB[Pubmed: 30323677]
Cellular Physiology and BiochemistrySinoporphyrin Sodium-Mediated Sonodynamic Therapy Inhibits RIP3 Expression and Induces Apoptosis in the H446 Small Cell Lung Cancer Cell Line[Pubmed: 30562734]